| Serial Number | 90796130 |
| Word Mark | THERORNA |
| Filing Date | Friday, June 25, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 12, 2023 |
| Registration Number | 7159975 |
| Registration Date | Tuesday, September 12, 2023 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 27, 2023 |
| Goods and Services | Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; opotherapy preparations; serotherapeutic medicines, namely, medical immune serums used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; biological preparations for medical purposes, namely, biological preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; medicines for human purposes, namely, medicines used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; chemical preparations for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; adjuvants for medical purposes; Blood for medical purposes; nutraceutical preparations for therapeutic or medical purposes; immunostimulants; Medical cell function activating drugs, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; tumor suppressing agents; Anti-sarcoma preparations; cytostatics for medical purposes; Pharmaceutical products for the prevention and treatment of cancer; all the foregoing using circular ribonucleic acid (RNA) |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 12, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | THERORNA Inc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Haidian Dist., Beijing 100082 CN |
| Party Name | THERORNA Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Haidian Dist., Beijing 100082 CN |
| Party Name | THERORNA Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Haidian Dist., Beijing 100082 CN |
| Event Date | Event Description |
| Tuesday, September 12, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 12, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 27, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 27, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 7, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, May 19, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, May 12, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 12, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, May 12, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, May 12, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, May 12, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 1, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 1, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 1, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 19, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 1, 2022 | ASSIGNED TO LIE |
| Monday, September 19, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 19, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 18, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 18, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, March 18, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 16, 2022 | ASSIGNED TO EXAMINER |
| Thursday, September 9, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 29, 2021 | NEW APPLICATION ENTERED |